Cargando…

Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

Advanced clear cell ovarian cancer (CCOC) is a highly fatal malignancy with a scarcity of effective treatment options. CCOC is inherently chemotherapy resistance, but the exact mechanism of this resistance has yet to be established. Prosurvival signaling, such as through the MAPK cascade, is one way...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowswell-Turner, Rachael B., Rutishauser, Jennifer A., Kim, Kyu Kwang, Khazan, Negar, Sivagnanalingam, Umayal, Jones, Aaron M., Singh, Rakesh K., Moore, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517847/ https://www.ncbi.nlm.nih.gov/pubmed/31082584 http://dx.doi.org/10.1016/j.tranon.2019.04.009

Ejemplares similares

Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines
por: Kim, Kyu Kwang, et al.
Publicado: (2020)

Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass
por: Moore, Richard George, et al.
Publicado: (2022)

Role of trypsin and protease-activated receptor-2 in ovarian cancer
por: Kim, Kyu Kwang, et al.
Publicado: (2020)

Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
por: Koike, Takao, et al.
Publicado: (2011)

Draft Genome Sequence of the Green Alga Scenedesmus acuminatus SAG 38.81
por: Astafyeva, Yekaterina, et al.
Publicado: (2020)

In vitro and in vivo Characterization of Host–Pathogen Interactions of the L3881 Candida albicans Clinical Isolate
por: Sucupira, Pedro H. F., et al.
Publicado: (2022)

Cisplatin inhibits MEK1/2
por: Yamamoto, Tetsu, et al.
Publicado: (2015)

Chemoimmunotherapy as long-term maintenance therapy for cancer
por: Egilmez, Nejat K., et al.
Publicado: (2012)

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
por: Kim, Kyu Kwang, et al.
Publicado: (2015)

Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6
por: James, Nicole E., et al.
Publicado: (2019)

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia
por: Sivagnanalingam, Umayal, et al.
Publicado: (2015)

Metastatic melanoma posing as a pelvic mass
por: Zywicki, Alexsaundra, et al.
Publicado: (2023)

Analytical performance of the FDA-cleared Parsortix(®) PC1 system
por: Templeman, Amy, et al.
Publicado: (2023)

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
por: Schweyer, S, et al.
Publicado: (2004)

CRISPR/Cas9 Edited RAS & MEK Mutant Cells Acquire BRAF and MEK Inhibitor Resistance with MEK1 Q56P Restoring Sensitivity to MEK/BRAF Inhibitor Combo and KRAS G13D Gaining Sensitivity to Immunotherapy
por: Turner, Elizabeth, et al.
Publicado: (2022)

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
por: Fung, M K L, et al.
Publicado: (2006)

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo
por: Khazan, Negar, et al.
Publicado: (2022)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
por: James, Nicole E., et al.
Publicado: (2020)

Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
por: Yang, Li, et al.
Publicado: (2017)

Transcriptional Activation of Gstp1 by MEK/ERK Signaling Confers Chemo-Resistance to Cisplatin in Lung Cancer Stem Cells
por: Li, Jingyuan, et al.
Publicado: (2019)

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
por: Khazan, Negar, et al.
Publicado: (2023)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

El jet's mek' /
por: Romero de Nieto, Carmen
Publicado: (1986)

The small molecule Mek1/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish
por: Hawkins, Thomas A, et al.
Publicado: (2008)

Roles of Integrins and Intracellular Molecules in the Migration and Neuritogenesis of Fetal Cortical Neurons: MEK Regulates Only the Neuritogenesis
por: Rout, Ujjwal K.
Publicado: (2013)

PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
por: Fu, Xueqiong, et al.
Publicado: (2014)

Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway
por: Kulshrestha, Arpita, et al.
Publicado: (2019)

Significant reduction in hospital-acquired thrombosis: impact of national risk assessment and real-time feedback
por: Rowswell, Huw Raymond, et al.
Publicado: (2017)

Cisplatin induces loop structures and condensation of single DNA molecules
por: Hou, Xi-Miao, et al.
Publicado: (2009)

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
por: Küsters-Vandevelde, Heidi VN, et al.
Publicado: (2014)

Regulation of Neural Cell Adhesion Molecule Polysialylation: Evidence for Nontranscriptional Control and Sensitivity to an Intracellular Pool of Calcium
por: Brusés, Juan L., et al.
Publicado: (1998)

MEK Inhibitors Potentiate Dexamethasone Lethality in Acute Lymphoblastic Leukemia Cells through the Pro-apoptotic Molecule BIM
por: Rambal, Anila A., et al.
Publicado: (2009)

Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
por: George, Aswathi A., et al.
Publicado: (2015)

Stomatin‐like protein 2 inhibits cisplatin‐induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells
por: Hu, Guolin, et al.
Publicado: (2018)

MEK genomics in development and disease
por: Bromberg-White, Jennifer L., et al.
Publicado: (2012)

New features in MEK retinopathy
por: Tyagi, Pallavi, et al.
Publicado: (2018)

Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors
por: Arkenau, Hendrik‐Tobias, et al.
Publicado: (2022)

Hæmaturia Due to the Presence of a Leech in the Urethra
por: Chand, Khazan
Publicado: (1885)

The immune synapse clears and excludes molecules above a size threshold
por: Cartwright, Adam N. R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_usqrti3kus9mjem51ehfges458